Global Human Coagulation Factor VIII Market Insights and Forecast to 2027

Global Human Coagulation Factor VIII Market Insights and Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Human Coagulation Factor VIII Product Introduction
1.2 Market by Type
1.2.1 Global Human Coagulation Factor VIII Market Size Growth Rate by Type
1.4.2 Recombinant Factor VIII
1.4.3 Plasma-derived Factor VIII
1.3 Market by Application
1.3.1 Global Human Coagulation Factor VIII Market Size Growth Rate by Application
1.3.2 Hemophilia A
1.3.3 Spontanous / Trauma
1.3.4 Surgical
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Human Coagulation Factor VIII Sales Estimates and Forecasts 2016-2027
2.2 Global Human Coagulation Factor VIII Revenue Estimates and Forecasts 2016-2027
2.3 Global Human Coagulation Factor VIII Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Human Coagulation Factor VIII Regions by Sales
2.4.1 Global Top Human Coagulation Factor VIII Regions by Sales (2016-2021)
2.4.2 Global Top Human Coagulation Factor VIII Regions by Sales (2022-2027)
2.5 Global Top Human Coagulation Factor VIII Regions by Revenue
2.5.1 Global Top Human Coagulation Factor VIII Regions by Revenue (2016-2021)
2.5.2 Global Top Human Coagulation Factor VIII Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Human Coagulation Factor VIII Sales by Manufacturers
3.1.1 Global Top Human Coagulation Factor VIII Manufacturers by Sales (2016-2021)
3.1.2 Global Top Human Coagulation Factor VIII Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Human Coagulation Factor VIII Sales in 2020
3.2 Global Human Coagulation Factor VIII Revenue by Manufacturers
3.2.1 Global Top Human Coagulation Factor VIII Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Human Coagulation Factor VIII Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Human Coagulation Factor VIII Revenue in 2020
3.3 Global Human Coagulation Factor VIII Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Human Coagulation Factor VIII Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Human Coagulation Factor VIII Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Human Coagulation Factor VIII Sales by Type
4.1.1 Global Human Coagulation Factor VIII Historical Sales by Type (2016-2021)
4.1.2 Global Human Coagulation Factor VIII Forecasted Sales by Type (2022-2027)
4.1.3 Global Human Coagulation Factor VIII Sales Market Share by Type (2016-2027)
4.2 Global Human Coagulation Factor VIII Revenue by Type
4.2.1 Global Human Coagulation Factor VIII Historical Revenue by Type (2016-2021)
4.2.2 Global Human Coagulation Factor VIII Forecasted Revenue by Type (2022-2027)
4.2.3 Global Human Coagulation Factor VIII Revenue Market Share by Type (2016-2027)
4.3 Global Human Coagulation Factor VIII Price by Type
4.3.1 Global Human Coagulation Factor VIII Price by Type (2016-2021)
4.3.2 Global Human Coagulation Factor VIII Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Human Coagulation Factor VIII Sales by Application
5.1.1 Global Human Coagulation Factor VIII Historical Sales by Application (2016-2021)
5.1.2 Global Human Coagulation Factor VIII Forecasted Sales by Application (2022-2027)
5.1.3 Global Human Coagulation Factor VIII Sales Market Share by Application (2016-2027)
5.2 Global Human Coagulation Factor VIII Revenue by Application
5.2.1 Global Human Coagulation Factor VIII Historical Revenue by Application (2016-2021)
5.2.2 Global Human Coagulation Factor VIII Forecasted Revenue by Application (2022-2027)
5.2.3 Global Human Coagulation Factor VIII Revenue Market Share by Application (2016-2027)
5.3 Global Human Coagulation Factor VIII Price by Application
5.3.1 Global Human Coagulation Factor VIII Price by Application (2016-2021)
5.3.2 Global Human Coagulation Factor VIII Price Forecast by Application (2022-2027)
6 North America
6.1 North America Human Coagulation Factor VIII Market Size by Type
6.1.1 North America Human Coagulation Factor VIII Sales by Type (2016-2027)
6.1.2 North America Human Coagulation Factor VIII Revenue by Type (2016-2027)
6.2 North America Human Coagulation Factor VIII Market Size by Application
6.2.1 North America Human Coagulation Factor VIII Sales by Application (2016-2027)
6.2.2 North America Human Coagulation Factor VIII Revenue by Application (2016-2027)
6.3 North America Human Coagulation Factor VIII Market Size by Country
6.3.1 North America Human Coagulation Factor VIII Sales by Country (2016-2027)
6.3.2 North America Human Coagulation Factor VIII Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Human Coagulation Factor VIII Market Size by Type
7.1.1 Europe Human Coagulation Factor VIII Sales by Type (2017-2027)
7.1.2 Europe Human Coagulation Factor VIII Revenue by Type (2017-2027)
7.2 Europe Human Coagulation Factor VIII Market Size by Application
7.2.1 Europe Human Coagulation Factor VIII Sales by Application (2017-2027)
7.2.2 Europe Human Coagulation Factor VIII Revenue by Application (2017-2027)
7.3 Europe Human Coagulation Factor VIII Market Size by Country
7.3.1 Europe Human Coagulation Factor VIII Sales by Country (2017-2027)
7.3.2 Europe Human Coagulation Factor VIII Revenue by Country (2017-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Human Coagulation Factor VIII Market Size by Type
8.1.1 Asia Pacific Human Coagulation Factor VIII Sales by Type (2018-2027)
8.1.2 Asia Pacific Human Coagulation Factor VIII Revenue by Type (2018-2027)
8.2 Asia Pacific Human Coagulation Factor VIII Market Size by Application
8.2.1 Asia Pacific Human Coagulation Factor VIII Sales by Application (2018-2027)
8.2.2 Asia Pacific Human Coagulation Factor VIII Revenue by Application (2018-2027)
8.3 Asia Pacific Human Coagulation Factor VIII Market Size by Region
8.3.1 Asia Pacific Human Coagulation Factor VIII Sales by Region (2018-2027)
8.3.2 Asia Pacific Human Coagulation Factor VIII Revenue by Region (2018-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Human Coagulation Factor VIII Market Size by Type
9.1.1 Latin America Human Coagulation Factor VIII Sales by Type (2019-2027)
9.1.2 Latin America Human Coagulation Factor VIII Revenue by Type (2019-2027)
9.2 Latin America Human Coagulation Factor VIII Market Size by Application
9.2.1 Latin America Human Coagulation Factor VIII Sales by Application (2019-2027)
9.2.2 Latin America Human Coagulation Factor VIII Revenue by Application (2019-2027)
9.3 Latin America Human Coagulation Factor VIII Market Size by Country
9.3.1 Latin America Human Coagulation Factor VIII Sales by Country (2019-2027)
9.3.2 Latin America Human Coagulation Factor VIII Revenue by Country (2019-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
6 Middle East and Africa
6.1 Middle East and Africa Human Coagulation Factor VIII Market Size by Type
6.1.1 Middle East and Africa Human Coagulation Factor VIII Sales by Type (2016-2027)
6.1.2 Middle East and Africa Human Coagulation Factor VIII Revenue by Type (2016-2027)
6.2 Middle East and Africa Human Coagulation Factor VIII Market Size by Application
6.2.1 Middle East and Africa Human Coagulation Factor VIII Sales by Application (2016-2027)
6.2.2 Middle East and Africa Human Coagulation Factor VIII Revenue by Application (2016-2027)
6.3 Middle East and Africa Human Coagulation Factor VIII Market Size by Country
6.3.1 Middle East and Africa Human Coagulation Factor VIII Sales by Country (2016-2027)
6.3.2 Middle East and Africa Human Coagulation Factor VIII Revenue by Country (2016-2027)
6.3.3 Turkey
6.3.4 Saudi Arabia
6.3.5 U.A.E
11 Company Profiles
11.1 Shire (Baxter)
11.1.1 Shire (Baxter) Corporation Information
11.1.2 Shire (Baxter) Overview
11.1.3 Shire (Baxter) Human Coagulation Factor VIII Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Shire (Baxter) Human Coagulation Factor VIII Product Description
11.1.5 Shire (Baxter) Related Developments
11.2 Bayer
11.2.1 Bayer Corporation Information
11.2.2 Bayer Overview
11.2.3 Bayer Human Coagulation Factor VIII Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Bayer Human Coagulation Factor VIII Product Description
11.2.5 Bayer Related Developments
11.3 CSL
11.3.1 CSL Corporation Information
11.3.2 CSL Overview
11.3.3 CSL Human Coagulation Factor VIII Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 CSL Human Coagulation Factor VIII Product Description
11.3.5 CSL Related Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Overview
11.4.3 Pfizer Human Coagulation Factor VIII Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Pfizer Human Coagulation Factor VIII Product Description
11.4.5 Pfizer Related Developments
11.5 Grifols
11.5.1 Grifols Corporation Information
11.5.2 Grifols Overview
11.5.3 Grifols Human Coagulation Factor VIII Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Grifols Human Coagulation Factor VIII Product Description
11.5.5 Grifols Related Developments
11.6 Biogen
11.6.1 Biogen Corporation Information
11.6.2 Biogen Overview
11.6.3 Biogen Human Coagulation Factor VIII Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Biogen Human Coagulation Factor VIII Product Description
11.6.5 Biogen Related Developments
11.7 Octapharma
11.7.1 Octapharma Corporation Information
11.7.2 Octapharma Overview
11.7.3 Octapharma Human Coagulation Factor VIII Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Octapharma Human Coagulation Factor VIII Product Description
11.7.5 Octapharma Related Developments
11.8 NovoNordisk
11.8.1 NovoNordisk Corporation Information
11.8.2 NovoNordisk Overview
11.8.3 NovoNordisk Human Coagulation Factor VIII Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 NovoNordisk Human Coagulation Factor VIII Product Description
11.8.5 NovoNordisk Related Developments
11.9 Greencross
11.9.1 Greencross Corporation Information
11.9.2 Greencross Overview
11.9.3 Greencross Human Coagulation Factor VIII Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Greencross Human Coagulation Factor VIII Product Description
11.9.5 Greencross Related Developments
11.10 Kedrion
11.10.1 Kedrion Corporation Information
11.10.2 Kedrion Overview
11.10.3 Kedrion Human Coagulation Factor VIII Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 Kedrion Human Coagulation Factor VIII Product Description
11.10.5 Kedrion Related Developments
11.1 Shire (Baxter)
11.1.1 Shire (Baxter) Corporation Information
11.1.2 Shire (Baxter) Overview
11.1.3 Shire (Baxter) Human Coagulation Factor VIII Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Shire (Baxter) Human Coagulation Factor VIII Product Description
11.1.5 Shire (Baxter) Related Developments
11.12 Hualan Bio
11.12.1 Hualan Bio Corporation Information
11.12.2 Hualan Bio Overview
11.12.3 Hualan Bio Human Coagulation Factor VIII Sales, Price, Revenue and Gross Margin (2016-2021)
11.12.4 Hualan Bio Product Description
11.12.5 Hualan Bio Related Developments
11.13 RAAS
11.13.1 RAAS Corporation Information
11.13.2 RAAS Overview
11.13.3 RAAS Human Coagulation Factor VIII Sales, Price, Revenue and Gross Margin (2016-2021)
11.13.4 RAAS Product Description
11.13.5 RAAS Related Developments
12 Value Chain and Sales Channels Analysis
12.1 Human Coagulation Factor VIII Value Chain Analysis
12.2 Human Coagulation Factor VIII Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Human Coagulation Factor VIII Production Mode & Process
12.4 Human Coagulation Factor VIII Sales and Marketing
12.4.1 Human Coagulation Factor VIII Sales Channels
12.4.2 Human Coagulation Factor VIII Distributors
12.5 Human Coagulation Factor VIII Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Human Coagulation Factor VIII Industry Trends
13.2 Human Coagulation Factor VIII Market Drivers
13.3 Human Coagulation Factor VIII Market Challenges
13.4 Human Coagulation Factor VIII Market Restraints
14 Key Findings in The Global Human Coagulation Factor VIII Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Human Coagulation Factor VIII Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Recombinant Factor VIII
Table 3. Major Manufacturers of Plasma-derived Factor VIII
Table 4. Global Human Coagulation Factor VIII Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 5. Global Human Coagulation Factor VIII Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Human Coagulation Factor VIII Sales by Region (2016-2021) & (Kg)
Table 7. Global Human Coagulation Factor VIII Sales Market Share by Region (2016-2021)
Table 8. Global Human Coagulation Factor VIII Sales by Region (2016-2021) & (Kg)
Table 9. Global Human Coagulation Factor VIII Sales Market Share by Region (2022-2027)
Table 10. Global Human Coagulation Factor VIII Revenue by Region (2016-2021) & (US$ Million)
Table 11. Global Human Coagulation Factor VIII Revenue Market Share by Region (2016-2021)
Table 12. Global Human Coagulation Factor VIII Revenue by Region (2022-2027) & (US$ Million)
Table 13. Global Human Coagulation Factor VIII Revenue Market Share by Region (2022-2027)
Table 14. Global Human Coagulation Factor VIII Sales by Manufacturers (2016-2021) & (Kg)
Table 15. Global Human Coagulation Factor VIII Sales Share by Manufacturers (2016-2021)
Table 16. Global Human Coagulation Factor VIII Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 17. Global Human Coagulation Factor VIII Revenue Share by Manufacturers (2016-2021)
Table 18. Human Coagulation Factor VIII Price by Manufacturers 2016-2021 (USD/Kg)
Table 19. Global Human Coagulation Factor VIII Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Human Coagulation Factor VIII by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Coagulation Factor VIII as of 2020)
Table 21. Human Coagulation Factor VIII Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Human Coagulation Factor VIII Product Offered
Table 23. Date of Manufacturers Enter into Human Coagulation Factor VIII Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Human Coagulation Factor VIII Sales by Type (2016-2021) & (Kg)
Table 26. Global Human Coagulation Factor VIII Sales by Type (2022-2027) & (Kg)
Table 27. Global Human Coagulation Factor VIII Sales Share by Type (2016-2021)
Table 28. Global Human Coagulation Factor VIII Sales Share by Type (2022-2027)
Table 29. Global Human Coagulation Factor VIII Revenue by Type (2016-2021) & (US$ Million)
Table 30. Global Human Coagulation Factor VIII Revenue by Type (2022-2027) & (US$ Million)
Table 31. Global Human Coagulation Factor VIII Revenue Share by Type (2016-2021)
Table 32. Global Human Coagulation Factor VIII Revenue Share by Type (2022-2027)
Table 33. Human Coagulation Factor VIII Price by Type (2016-2021) & (USD/Kg)
Table 34. Global Human Coagulation Factor VIII Price Forecast by Type (2022-2027) & (USD/Kg)
Table 35. Global Human Coagulation Factor VIII Sales by Application (2016-2021) & (Kg)
Table 36. Global Human Coagulation Factor VIII Sales by Application (2022-2027) & (Kg)
Table 37. Global Human Coagulation Factor VIII Sales Share by Application (2016-2021)
Table 38. Global Human Coagulation Factor VIII Sales Share by Application (2022-2027)
Table 39. Global Human Coagulation Factor VIII Revenue by Application (2016-2021) & (US$ Million)
Table 40. Global Human Coagulation Factor VIII Revenue by Application (2022-2027) & (US$ Million)
Table 41. Global Human Coagulation Factor VIII Revenue Share by Application (2016-2021)
Table 42. Global Human Coagulation Factor VIII Revenue Share by Application (2022-2027)
Table 43. Human Coagulation Factor VIII Price by Application (2016-2021) & (USD/Kg)
Table 44. Global Human Coagulation Factor VIII Price Forecast by Application (2022-2027) & (USD/Kg)
Table 45. North America Human Coagulation Factor VIII Sales by Type (2016-2021) & (Kg)
Table 46. North America Human Coagulation Factor VIII Sales by Type (2022-2027) & (Kg)
Table 47. North America Human Coagulation Factor VIII Revenue by Type (2016-2021) & (US$ Million)
Table 48. North America Human Coagulation Factor VIII Revenue by Type (2022-2027) & (US$ Million)
Table 49. North America Human Coagulation Factor VIII Sales by Application (2016-2021) & (Kg)
Table 50. North America Human Coagulation Factor VIII Sales by Application (2022-2027) & (Kg)
Table 51. North America Human Coagulation Factor VIII Revenue by Application (2016-2021) & (US$ Million)
Table 52. North America Human Coagulation Factor VIII Revenue by Application (2022-2027) & (US$ Million)
Table 53. North America Human Coagulation Factor VIII Sales by Country (2016-2021) & (Kg)
Table 54. North America Human Coagulation Factor VIII Sales by Country (2022-2027) & (Kg)
Table 55. North America Human Coagulation Factor VIII Revenue by Country (2016-2021) & (US$ Million)
Table 56. North America Human Coagulation Factor VIII Revenue by Country (2022-2027) & (US$ Million)
Table 57. Europe Human Coagulation Factor VIII Sales by Type (2016-2021) & (Kg)
Table 58. Europe Human Coagulation Factor VIII Sales by Type (2022-2027) & (Kg)
Table 59. Europe Human Coagulation Factor VIII Revenue by Type (2016-2021) & (US$ Million)
Table 60. Europe Human Coagulation Factor VIII Revenue by Type (2022-2027) & (US$ Million)
Table 61. Europe Human Coagulation Factor VIII Sales by Application (2016-2021) & (Kg)
Table 62. Europe Human Coagulation Factor VIII Sales by Application (2022-2027) & (Kg)
Table 63. Europe Human Coagulation Factor VIII Revenue by Application (2016-2021) & (US$ Million)
Table 64. Europe Human Coagulation Factor VIII Revenue by Application (2022-2027) & (US$ Million)
Table 65. Europe Human Coagulation Factor VIII Sales by Country (2016-2021) & (Kg)
Table 66. Europe Human Coagulation Factor VIII Sales by Country (2022-2027) & (Kg)
Table 67. Europe Human Coagulation Factor VIII Revenue by Country (2016-2021) & (US$ Million)
Table 68. Europe Human Coagulation Factor VIII Revenue by Country (2022-2027) & (US$ Million)
Table 69. Asia Pacific Human Coagulation Factor VIII Sales by Type (2016-2021) & (Kg)
Table 70. Asia Pacific Human Coagulation Factor VIII Sales by Type (2022-2027) & (Kg)
Table 71. Asia Pacific Human Coagulation Factor VIII Revenue by Type (2016-2021) & (US$ Million)
Table 72. Asia Pacific Human Coagulation Factor VIII Revenue by Type (2022-2027) & (US$ Million)
Table 73. Asia Pacific Human Coagulation Factor VIII Sales by Application (2016-2021) & (Kg)
Table 74. Asia Pacific Human Coagulation Factor VIII Sales by Application (2022-2027) & (Kg)
Table 75. Asia Pacific Human Coagulation Factor VIII Revenue by Application (2016-2021) & (US$ Million)
Table 76. Asia Pacific Human Coagulation Factor VIII Revenue by Application (2022-2027) & (US$ Million)
Table 77. Asia Pacific Human Coagulation Factor VIII Sales by Region (2016-2021) & (Kg)
Table 78. Asia Pacific Human Coagulation Factor VIII Sales by Region (2022-2027) & (Kg)
Table 79. Asia Pacific Human Coagulation Factor VIII Revenue by Region (2016-2021) & (US$ Million)
Table 80. Asia Pacific Human Coagulation Factor VIII Revenue by Region (2022-2027) & (US$ Million)
Table 81. Latin America Human Coagulation Factor VIII Sales by Type (2016-2021) & (Kg)
Table 82. Latin America Human Coagulation Factor VIII Sales by Type (2022-2027) & (Kg)
Table 83. Latin America Human Coagulation Factor VIII Revenue by Type (2016-2021) & (US$ Million)
Table 84. Latin America Human Coagulation Factor VIII Revenue by Type (2022-2027) & (US$ Million)
Table 85. Latin America Human Coagulation Factor VIII Sales by Application (2016-2021) & (Kg)
Table 86. Latin America Human Coagulation Factor VIII Sales by Application (2022-2027) & (Kg)
Table 87. Latin America Human Coagulation Factor VIII Revenue by Application (2016-2021) & (US$ Million)
Table 88. Latin America Human Coagulation Factor VIII Revenue by Application (2022-2027) & (US$ Million)
Table 89. Latin America Human Coagulation Factor VIII Sales by Country (2016-2021) & (Kg)
Table 90. Latin America Human Coagulation Factor VIII Sales by Country (2022-2027) & (Kg)
Table 91. Latin America Human Coagulation Factor VIII Revenue by Country (2016-2021) & (US$ Million)
Table 92. Latin America Human Coagulation Factor VIII Revenue by Country (2022-2027) & (US$ Million)
Table 93. Middle East and Africa Human Coagulation Factor VIII Sales by Type (2016-2021) & (Kg)
Table 94. Middle East and Africa Human Coagulation Factor VIII Sales by Type (2022-2027) & (Kg)
Table 95. Middle East and Africa Human Coagulation Factor VIII Revenue by Type (2016-2021) & (US$ Million)
Table 96. Middle East and Africa Human Coagulation Factor VIII Revenue by Type (2022-2027) & (US$ Million)
Table 97. Middle East and Africa Human Coagulation Factor VIII Sales by Application (2016-2021) & (Kg)
Table 98. Middle East and Africa Human Coagulation Factor VIII Sales by Application (2022-2027) & (Kg)
Table 99. Middle East and Africa Human Coagulation Factor VIII Revenue by Application (2016-2021) & (US$ Million)
Table 100. Middle East and Africa Human Coagulation Factor VIII Revenue by Application (2022-2027) & (US$ Million)
Table 101. Middle East and Africa Human Coagulation Factor VIII Sales by Country (2016-2021) & (Kg)
Table 102. Middle East and Africa Human Coagulation Factor VIII Sales by Country (2022-2027) & (Kg)
Table 103. Middle East and Africa Human Coagulation Factor VIII Revenue by Country (2016-2021) & (US$ Million)
Table 104. Middle East and Africa Human Coagulation Factor VIII Revenue by Country (2022-2027) & (US$ Million)
Table 105. Shire (Baxter) Corporation Information
Table 106. Shire (Baxter) Description and Major Businesses
Table 107. Shire (Baxter) Human Coagulation Factor VIII Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 108. Shire (Baxter) Human Coagulation Factor VIII Product
Table 109. Shire (Baxter) Recent Developments
Table 110. Bayer Corporation Information
Table 111. Bayer Description and Major Businesses
Table 112. Bayer Human Coagulation Factor VIII Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 113. Bayer Human Coagulation Factor VIII Product
Table 114. Bayer Recent Developments
Table 115. CSL Corporation Information
Table 116. CSL Description and Major Businesses
Table 117. CSL Human Coagulation Factor VIII Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 118. CSL Human Coagulation Factor VIII Product
Table 119. CSL Recent Developments
Table 120. Pfizer Corporation Information
Table 121. Pfizer Description and Major Businesses
Table 122. Pfizer Human Coagulation Factor VIII Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 123. Pfizer Human Coagulation Factor VIII Product
Table 124. Pfizer Recent Developments
Table 125. Grifols Corporation Information
Table 126. Grifols Description and Major Businesses
Table 127. Grifols Human Coagulation Factor VIII Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 128. Grifols Human Coagulation Factor VIII Product
Table 129. Grifols Recent Developments
Table 130. Biogen Corporation Information
Table 131. Biogen Description and Major Businesses
Table 132. Biogen Human Coagulation Factor VIII Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 133. Biogen Human Coagulation Factor VIII Product
Table 134. Biogen Recent Developments
Table 135. Octapharma Corporation Information
Table 136. Octapharma Description and Major Businesses
Table 137. Octapharma Human Coagulation Factor VIII Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 138. Octapharma Human Coagulation Factor VIII Product
Table 139. Octapharma Recent Developments
Table 140. NovoNordisk Corporation Information
Table 141. NovoNordisk Description and Major Businesses
Table 142. NovoNordisk Human Coagulation Factor VIII Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 143. NovoNordisk Human Coagulation Factor VIII Product
Table 144. NovoNordisk Recent Developments
Table 145. Greencross Corporation Information
Table 146. Greencross Description and Major Businesses
Table 147. Greencross Human Coagulation Factor VIII Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 148. Greencross Human Coagulation Factor VIII Product
Table 149. Greencross Recent Developments
Table 150. Kedrion Corporation Information
Table 151. Kedrion Description and Major Businesses
Table 152. Kedrion Human Coagulation Factor VIII Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 153. Kedrion Human Coagulation Factor VIII Product
Table 154. Kedrion Recent Developments
Table 155. BPL Corporation Information
Table 156. BPL Description and Major Businesses
Table 157. BPL Human Coagulation Factor VIII Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 158. BPL Human Coagulation Factor VIII Product
Table 159. BPL Recent Developments
Table 160. Hualan Bio Corporation Information
Table 161. Hualan Bio Description and Major Businesses
Table 162. Hualan Bio Human Coagulation Factor VIII Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 163. Hualan Bio Human Coagulation Factor VIII Product
Table 164. Hualan Bio Recent Developments
Table 165. RAAS Corporation Information
Table 166. RAAS Description and Major Businesses
Table 167. RAAS Human Coagulation Factor VIII Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 168. RAAS Human Coagulation Factor VIII Product
Table 169. RAAS Recent Developments
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Human Coagulation Factor VIII Distributors List
Table 173. Human Coagulation Factor VIII Customers List
Table 174. Human Coagulation Factor VIII Market Trends
Table 175. Human Coagulation Factor VIII Market Drivers
Table 176. Human Coagulation Factor VIII Market Challenges
Table 177. Human Coagulation Factor VIII Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Coagulation Factor VIII Product Picture
Figure 2. Global Human Coagulation Factor VIII Market Share by Type in 2020 & 2027
Figure 3. Recombinant Factor VIII Product Picture
Figure 4. Plasma-derived Factor VIII Product Picture
Figure 5. Global Human Coagulation Factor VIII Sales Market Share by Application in 2020 & 2027
Figure 6. Hemophilia A
Figure 7. Spontanous / Trauma
Figure 8. Surgical
Figure 9. Other
Figure 10. Human Coagulation Factor VIII Report Years Considered
Figure 11. Global Human Coagulation Factor VIII Sales 2016-2027 (Kg)
Figure 12. Global Human Coagulation Factor VIII Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Human Coagulation Factor VIII Revenue 2016-2027 (US$ Million)
Figure 14. Global Human Coagulation Factor VIII Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 15. Global Human Coagulation Factor VIII Sales Market Share by Region (2016-2021)
Figure 16. Global Human Coagulation Factor VIII Sales Market Share by Region (2022-2027)
Figure 17. North America Human Coagulation Factor VIII Sales YoY (2016-2027) & (Kg)
Figure 18. North America Human Coagulation Factor VIII Revenue YoY (2016-2027) & (US$ Million)
Figure 19. Europe Human Coagulation Factor VIII Sales YoY (2016-2027) & (Kg)
Figure 20. Europe Human Coagulation Factor VIII Revenue YoY (2016-2027) & (US$ Million)
Figure 21. Asia-Pacific Human Coagulation Factor VIII Sales YoY (2016-2027) & (Kg)
Figure 22. Asia-Pacific Human Coagulation Factor VIII Revenue YoY (2016-2027) & (US$ Million)
Figure 23. Latin America Human Coagulation Factor VIII Sales YoY (2016-2027) & (Kg)
Figure 24. Latin America Human Coagulation Factor VIII Revenue YoY (2016-2027) & (US$ Million)
Figure 25. Middle East & Africa Human Coagulation Factor VIII Sales YoY (2016-2027) & (Kg)
Figure 26. Middle East & Africa Human Coagulation Factor VIII Revenue YoY (2016-2027) & (US$ Million)
Figure 27. The Top 10 and Top 5 Players Market Share by Human Coagulation Factor VIII Sales in 2020
Figure 28. The Top 10 and Top 5 Players Market Share by Human Coagulation Factor VIII Revenue in 2020
Figure 29. Human Coagulation Factor VIII Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 30. Global Human Coagulation Factor VIII Sales Market Share by Type (2016-2027)
Figure 31. Global Human Coagulation Factor VIII Revenue Market Share by Type (2016-2027)
Figure 32. Global Human Coagulation Factor VIII Sales Market Share by Application (2016-2027)
Figure 33. Global Human Coagulation Factor VIII Revenue Market Share by Application (2016-2027)
Figure 34. North America Human Coagulation Factor VIII Sales Market Share by Type (2016-2027)
Figure 35. North America Human Coagulation Factor VIII Revenue Market Share by Type (2016-2027)
Figure 36. North America Human Coagulation Factor VIII Sales Market Share by Application (2016-2027)
Figure

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Human Coagulation Factor VII Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 83

According to our LPI (LP Information) latest study, the global Human Coagulation Factor VII market size was valued at US$ 2232.8 million in 2023. With growing demand in downstream market, the Human Coagulation Factor VII is forecast to a readjusted size of US$ 4339.6 million by 2030 with a CAGR of 10.0% during review period. The research report highlights the growth potential of the global Human Coagulation Factor VII market. Human Coagulation Factor VII are expected to show stable growt......

Global Human Coagulation Factor VIII Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116

According to our LPI (LP Information) latest study, the global Human Coagulation Factor VIII market size was valued at US$ 10010 million in 2023. With growing demand in downstream market, the Human Coagulation Factor VIII is forecast to a readjusted size of US$ 15590 million by 2030 with a CAGR of 6.5% during review period. The research report highlights the growth potential of the global Human Coagulation Factor VIII market. Human Coagulation Factor VIII are expected to show stable grow......

Global D-Dimer Market Research Report 2023

Published: 05-Dec-2023        Price: US 2900 Onwards        Pages: 97

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global D-dimer market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Abbott Laboratories - F. Hoffman-La Roche - Beckman Coulter - Abbott - Bio/Data - Becton Dickinson - Sysmex - Siemens Healthcare - Trinit......

Global Human Coagulation Factor VII Professional Survey Report 2023, Forecast to 2028

Published: 09-Nov-2023        Price: US 3280 Onwards        Pages: 104

Factor VII (EC 3.4. 21.21, blood-coagulation factor VIIa, activated blood coagulation factor VII, formerly known as proconvertin) is one of the proteins that causes blood to clot in the coagulation cascade. It is an enzyme of the serine protease class. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way,......

Global Human Coagulation Factor VII Market Research Report 2023, Forecast to 2028

Published: 09-Nov-2023        Price: US 2680 Onwards        Pages: 167

Factor VII (EC 3.4. 21.21, blood-coagulation factor VIIa, activated blood coagulation factor VII, formerly known as proconvertin) is one of the proteins that causes blood to clot in the coagulation cascade. It is an enzyme of the serine protease class. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way,......

Global Human Coagulation Factor Viii Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 24-Aug-2023        Price: US 3380 Onwards        Pages: 98

Market Overview of Global Human Coagulation Factor Viii market: According to our latest research, the global Human Coagulation Factor Viii market looks promising in the next 5 years. As of 2022, the global Human Coagulation Factor Viii market was estimated at USD 9757.48 million, and it's anticipated to reach USD 17207.33 million in 2028, with a CAGR of 9.92% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehe......

Global Coagulation Tests Market Insights, Forecast to 2029

Published: 16-Jun-2023        Price: US 4900 Onwards        Pages: 109

Globally, the hematology market is assessed as a mature market and is characterized by intense competition with a high demand for clinical coagulation tests. With the increase in the number of cardiovascular surgical procedures being performed, there has been a considerable need for coagulation testing. Today, an increasing number of patients are using anticoagulants after having a mechanical heart valve implantation performed, as well as to prevent coagulation accidents like pulmonary embolisms......

Global D-dimer Market Insights, Forecast to 2029

Published: 14-Jun-2023        Price: US 4900 Onwards        Pages: 107

The global D-dimer market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The US & Canada market for D-dimer is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029. The China market for D-dimer is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during......

Global Coagulation Tests Market Research Report 2023

Published: 11-Apr-2023        Price: US 2900 Onwards        Pages: 86

Globally, the hematology market is assessed as a mature market and is characterized by intense competition with a high demand for clinical coagulation tests. With the increase in the number of cardiovascular surgical procedures being performed, there has been a considerable need for coagulation testing. Today, an increasing number of patients are using anticoagulants after having a mechanical heart valve implantation performed, as well as to prevent coagulation accidents like pulmonary embolisms......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs